10x Genomics (TXG) Tops Q2 EPS by 10c, Beats on Revenue

Go back to 10x Genomics (TXG) Tops Q2 EPS by 10c, Beats on Revenue

10x Genomics Reports Second Quarter 2026 Financial Results

August 6, 2026 4:02 PM EDT

PLEASANTON, Calif., Aug. 6, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today reported financial results for the second quarter ended... More